scroll
LEARN MORE
Buy Hold Sell: The best and worst performers of FY25
Close
Thursday 11th September – Dow off -220pts, SPI off -20pts
Close
Wednesday 10th September – Dow up +196pts, SPI down -4pts
Close
14 DAYS FREE ACCESS
Join Market Matters and get full access
to all our Opinion + Action
CSL $200.97
20 MINUTE DELAYED
ANALYSIS
OPINION
ACTION
more
i
PERFORMANCE
i
| SHARE PRICE ACTIVITY | |
|---|---|
| Last (Price) | 200.97 |
| Change | -0.10 (-0.05) |
| Bid / Ask | 200.96 - 200.98 |
| Volume | 449,134 |
| Turnover | 93,430,407 |
| Open | 200.58 |
| Day Range | 199.62 - 201.47 |
| VWAP | 200.38 |
| Prev Close | 201.07 |
| Last Trade | 18/09 11:13am (AEST) |
i
| KEY INFORMATION | |
|---|---|
| Sector | Healthcare |
| Shares Issued | 484,109,213 |
| NTA/Share | 0.00 |
| Last Dividend | 2.45 |
| Dividend Ex Date | 09 SEP 2025 |
| Dividend Pay Date | 03 OCT 2025 |
i
| CURRENT () | |
|---|---|
| Revenue | 14,800.00 |
| EBITDA | 4,894.00 |
| Profit | 2,907.00 |
| Earnings Per Share (EPS) | 0 |
| Dividend Per Share (DPS) | 0 |
| Yield % | 2.25 |
| Market Cap | 0 |
| Price to Earnings Ratio (P/E) | 21.24 |
i
TARGET PRICE FORECAST
i
| ESTIMATES () | |
|---|---|
| Revenue | 16,248.03 |
| EBITDA | 5,633.85 |
| Profit | 3,408.36 |
| Earnings Per Share (EPS) | 7.10 |
| Dividend Per Share (DPS) | 3.04 |
i
BROKER CONSENSUS RECOMMENDATION
BUY
SELL
Target Price
296.64
Lt Growth Rate
12.85
Recommendation (BUY)
2.06
ACTION
CSL
UPDATED
16/09/2025 18:24
ACTIVE
CSL
UPDATED
16/09/2025 18:23
ACTIVE
MM is adding to CSL in Active Growth Portfolio, targeting a 5% portfolio weighting
Add To Hit List
CSL
UPDATED
20/08/2025 09:47
CSL
UPDATED
20/08/2025 08:26
CSL
UPDATED
14/08/2025 09:51
CSL
UPDATED
10/07/2025 10:09
CSL
UPDATED
10/07/2025 10:07
MM are buying CSL in the Active Growth Portfolio, allocating 4% around $250
Add To Hit List
CSL
UPDATED
01/05/2025 09:39
CSL
UPDATED
27/02/2025 11:05
CSL
UPDATED
21/02/2025 17:30
MM are selling CSL in the Active Growth Portfolio, taking a loss around $259
Add To Hit List
Business Summary
CSL Limited (CSL) is a global biotechnology company that develops and delivers innovative medicines that save lives, protect public health and help people with life-threatening medical conditions live full lives. CSL is also involved in research, development, manufacture, marketing and distribution of biopharmaceutical and allied products. CSL's operating model for its two businesses, CSL Behring and Seqirus.
Tagged video
Close
Video
WATCH
Pulse Check Webinar: Opportunities in the unloved parts of the market
Recorded Wednesday 27st September
WATCH
Pulse Check Webinar: Opportunities in the unloved parts of the market
Recorded Wednesday 27st September
Relevant suggested news and content from the site
Video
WATCH
Buy Hold Sell: The best and worst performers of FY25
James Gerrish & Henry Jennings
Podcast
LISTEN
Thursday 11th September – Dow off -220pts, SPI off -20pts
Daily Podcast Direct from the Desk
Podcast
LISTEN
Wednesday 10th September – Dow up +196pts, SPI down -4pts
Daily Podcast Direct from the Desk
Only available to Members
Take a free 14 day Market Matters trial – full access to all our reports, portfolios, positions, buy and sell recommendations. Access the latest views on the latest developments from professional money managers. It's free and no payment details are required
For membership options and pricing.
Click here
